{"id":151610,"date":"2023-08-07T10:31:01","date_gmt":"2023-08-07T14:31:01","guid":{"rendered":"https:\/\/44.250.171.167\/?p=151610"},"modified":"2023-08-07T10:31:02","modified_gmt":"2023-08-07T14:31:02","slug":"caplin-point-laboratories-ltd-q1fy24-21-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q1fy24-21-rise-in-profits\/","title":{"rendered":"Caplin Point Laboratories Ltd Q1FY24; 21% rise in Profits"},"content":{"rendered":"\n

Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.<\/p>\n\n\n\n

Financial Results:<\/strong><\/p>\n\n\n\n

Caplin Point Laboratories Ltd reported Revenues for Q1FY24 of \u20b9395.00 Crores up from \u20b9346.00 Crore year on year, a rise of 14.16%.<\/p>\n\n\n\n

Total Expenses for Q1FY24 of \u20b9280.00 Crores up from \u20b9255.00 Crores year on year, a rise of 9.8%.<\/p>\n\n\n\n

Consolidated Net Profit of \u20b9104.00 Crores up 20.93% from \u20b986.00 Crores in the same quarter of the previous year.<\/p>\n\n\n\n

The Earnings per Share is \u20b913.62, up 21.50% from \u20b911.21 in the same quarter of the previous year.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n

*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"

Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q1FY24 of \u20b9395.00 Crores up from \u20b9346.00 Crore year on year, a rise of 14.16%. Total Expenses for […]<\/p>\n","protected":false},"author":1932,"featured_media":151612,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[1115],"class_list":["post-151610","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-313.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":165984,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q2fy25-13-rise-in-profits\/","url_meta":{"origin":151610,"position":0},"title":"Caplin Point Laboratories Ltd Q2FY25; 13% rise in Profits","author":"Divyansh_Kasana","date":"December 10, 2024","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q2FY25 of \u20b9483.00 Crores up from \u20b9410.00 Crore year on year, a rise\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168907,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q4fy25-20-rise-in-profits\/","url_meta":{"origin":151610,"position":1},"title":"Caplin Point Laboratories Ltd Q4FY25; 20% rise in Profits","author":"Divyansh_Kasana","date":"June 26, 2025","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q4FY25 of \u20b9502.00 Crores up from \u20b9453.00 Crore year on year, a rise\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167390,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q3fy25-17-rise-in-profits\/","url_meta":{"origin":151610,"position":2},"title":"Caplin Point Laboratories Ltd Q3FY25; 17% rise in Profits","author":"Divyansh_Kasana","date":"March 14, 2025","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q3FY25 of \u20b9493.00 Crores up from \u20b9436.00 Crore year on year, a rise\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161801,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q4fy24-20-rise-in-profits\/","url_meta":{"origin":151610,"position":3},"title":"Caplin Point Laboratories Ltd Q4FY24; 20% rise in Profits","author":"Divyansh_Kasana","date":"June 3, 2024","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q4FY24 of \u20b9453.00 Crores up from \u20b9389.00 Crore year on year, a rise\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157158,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q4fy23-25-rise-in-profits\/","url_meta":{"origin":151610,"position":4},"title":"Caplin Point Laboratories Ltd Q4FY23; 25% rise in Profits","author":"Divyansh_Kasana","date":"December 7, 2023","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q4FY23 of \u20b9389.00 Crores up from \u20b9339.00 Crore year on year, a rise\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152278,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-ltd-q1fy24-13-rise-in-profits\/","url_meta":{"origin":151610,"position":5},"title":"Ipca Laboratories Ltd Q1FY24; 13% rise in Profits","author":"Hardik Bhandare","date":"August 10, 2023","format":false,"excerpt":"Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68) Financial Results: Ipca Laboratories Ltd reported Revenues for Q1FY24 of \u20b91,588.00 Crores up from \u20b91,586.00 Crore year on year, a rise of 0.13%. Total Expenses for Q1FY24 of \u20b91,380.00 Crores down from\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/151610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=151610"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/151610\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/151612"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=151610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=151610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=151610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}